Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07782164

Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)

Sponsor: Amsterdam UMC, location VUmc

View on ClinicalTrials.gov

Summary

The goal of this single-center observational cohort study, based on a registry combining retrospectively and prospectively collected data, is to investigate the short- and long-term effects of irreversible electroporation (IRE) in men and women over the age of 18 who receive IRE for recurrence of pelvic tumors not suitable for other local treatment options such as surgery, thermal ablation, and radiotherapy. The main question it aims to answer is whether IRE is safe in this population, and secondarily, whether it is effective in controlling local tumor recurrence.

Official title: Irreversible Electroporation (IRE) of Recurrent Pelvic Tumors: the PELFIRE Study.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

27

Start Date

2025-04-18

Completion Date

2028-07

Last Updated

2026-08-28

Healthy Volunteers

No

Interventions

PROCEDURE

Irreversible electroporation

Irreversible electroporation

Locations (1)

Amsterdam UMC

Amsterdam, North Holland, Netherlands